title: Computational model for nanocarrier binding to endothelium validated using in vivo, in vitro, and atomic force microscopy experiments.
abstract: A computational methodology based on Metropolis Monte Carlo (MC) and the weighted histogram analysis method (WHAM) has been developed to calculate the absolute binding free energy between functionalized nanocarriers (NC) and endothelial cell (EC) surfaces. The calculated NC binding free energy landscapes yield binding affinities that agree quantitatively when directly compared against analogous measurements of specific antibody-coated NCs (100 nm in diameter) to intracellular adhesion molecule-1 (ICAM-1) expressing EC surface in in vitro cell-culture experiments. The effect of antibody surface coverage (σ(s)) of NC on binding simulations reveals a threshold σ(s) value below which the NC binding affinities reduce drastically and drop lower than that of single anti-ICAM-1 molecule to ICAM-1. The model suggests that the dominant effect of changing σ(s) around the threshold is through a change in multivalent interactions; however, the loss in translational and rotational entropies are also important. Consideration of shear flow and glycocalyx does not alter the computed threshold of antibody surface coverage. The computed trend describing the effect of σ(s) on NC binding agrees remarkably well with experimental results of in vivo targeting of the anti-ICAM-1 coated NCs to pulmonary endothelium in mice. Model results are further validated through close agreement between computed NC rupture-force distribution and measured values in atomic force microscopy (AFM) experiments. The three-way quantitative agreement with AFM, in vitro (cell-culture), and in vivo experiments establishes the mechanical, thermodynamic, and physiological consistency of our model. Hence, our computational protocol represents a quantitative and predictive approach for model-driven design and optimization of functionalized nanocarriers in targeted vascular drug delivery.
authors.affiliation: Department of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104, USA.
authors.forename: Jin
authors.initials: J
authors.lastname: Liu
authors.forename: Gregory E R
authors.initials: GE
authors.lastname: Weller
authors.forename: Blaine
authors.initials: B
authors.lastname: Zern
authors.forename: Portonovo S
authors.initials: PS
authors.lastname: Ayyaswamy
authors.forename: David M
authors.initials: DM
authors.lastname: Eckmann
authors.forename: Vladimir R
authors.initials: VR
authors.lastname: Muzykantov
authors.forename: Ravi
authors.initials: R
authors.lastname: Radhakrishnan
mesh_terms: D000818:Animals; D000906:Antibodies / Q000008:administration & dosage / Q000378:metabolism; D055592:Biophysical Phenomena; D004337:Drug Carriers / Q000378:metabolism*; D016503:Drug Delivery Systems; D042783:Endothelial Cells / Q000378:metabolism*; D005260:Female; D019276:Glycocalyx / Q000378:metabolism; D066298:In Vitro Techniques; D018799:Intercellular Adhesion Molecule-1 / Q000276:immunology / Q000378:metabolism; D008168:Lung / Q000098:blood supply / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D018625:Microscopy, Atomic Force; D008954:Models, Biological; D009010:Monte Carlo Method; D054118:Nanospheres; D013816:Thermodynamics
chemical_list: D000906:Antibodies; D004337:Drug Carriers; D018799:Intercellular Adhesion Molecule-1
references.citation: J Phys Chem C Nanomater Interfaces. 2007 Nov 1;111(43):15848-15856
references.pmid: 19081797
references.citation: Proc Natl Acad Sci U S A. 2008 Sep 23;105(38):14265-70
references.pmid: 18809927
references.citation: J Phys Chem B. 2005 Apr 7;109(13):6448-56
references.pmid: 16851719
references.citation: Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7988-95
references.pmid: 12810946
references.citation: Biophys J. 2002 Oct;83(4):2270-9
references.pmid: 12324444
references.citation: Pharm Res. 2008 Aug;25(8):1815-21
references.pmid: 18373181
references.citation: Science. 2004 Mar 19;303(5665):1818-22
references.pmid: 15031496
references.citation: Biophys J. 1984 Jun;45(6):1051-64
references.pmid: 6743742
references.citation: Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):11901-4
references.pmid: 17620615
references.citation: Biomaterials. 2010 Feb;31(6):1392-402
references.pmid: 19954839
references.citation: Proc Natl Acad Sci U S A. 2007 May 22;104(21):8691-6
references.pmid: 17485668
references.citation: J Biol Chem. 2003 Mar 21;278(12):10556-61
references.pmid: 12522146
references.citation: Biophys J. 1997 Apr;72(4):1541-55
references.pmid: 9083660
references.citation: Science. 1998 Jan 16;279(5349):377-80
references.pmid: 9430587
references.citation: J Pharmacol Exp Ther. 2006 Jun;317(3):1161-9
references.pmid: 16505161
references.citation: Adv Drug Deliv Rev. 2009 Sep 30;61(11):931-9
references.pmid: 19596034
references.citation: Nat Biotechnol. 2001 Oct;19(10):958-61
references.pmid: 11581662
references.citation: Biorheology. 2009;46(4):323-41
references.pmid: 19721193
references.citation: Langmuir. 2008 Aug 19;24(16):8821-32
references.pmid: 18630976
references.citation: Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):4930-4
references.pmid: 16549762
references.citation: Proc Natl Acad Sci U S A. 2006 Sep 5;103(36):13509-13
references.pmid: 16938891
references.citation: Biophys J. 2003 Jul;85(1):637-45
references.pmid: 12829517
references.citation: Proc Natl Acad Sci U S A. 2005 May 10;102(19):6825-30
references.pmid: 15867154
references.citation: Am J Physiol Heart Circ Physiol. 2002 Oct;283(4):H1282-91
references.pmid: 12234777
references.citation: J Am Chem Soc. 2009 Sep 9;131(35):12780-91
references.pmid: 19681607
references.citation: Ann Surg. 1993 Nov;218(5):593-609
references.pmid: 8239773
references.citation: Nat Biotechnol. 2006 May;24(5):582-6
references.pmid: 16633350
references.citation: Mol Ther. 2008 Aug;16(8):1450-8
references.pmid: 18560419
references.citation: Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2050-5
references.pmid: 17267609